Primary Analysis Of Jump, A Phase 3b, Expanded-Access Study Evaluating The Safety And Efficacy Of Ruxolitinib In Patients With Myelofibrosis, Including Those With Low Platelet Counts (Vol 189, Pg 888, 2020)
BRITISH JOURNAL OF HAEMATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要